View Clinical Trial (Medical Research Study)
Regulation of Lipoprotein(a) Metabolism in Humans With Reference to Ethnicity
| City: |
|
Mather |
| State: |
|
California |
| Zip Code: |
|
95655 |
| Conditions: |
|
Healthy - Heart Disease |
| Purpose: |
|
The purpose of this study is to determine whether lipoprotein(a), also called Lp(a), is a
risk factor for cardiovascular (heart) disease. Lipoproteins are tiny particles that
circulate in the blood. They contain cholesterol, fat, and protein in varying amounts
depending on the body's need. Higher levels of lipoproteins in the blood can cause an
increased risk of heart disease.
The investigators believe that by studying the Lp(a) lipoprotein in Caucasians and African
Americans, the investigators can assess for genetic variation factors related to
cardiovascular (heart) disease. The investigators will be looking at 100 African-American
families and 100 Caucasian families to confirm whether a higher Lp(a) level is an indicator
of a higher risk for heart disease.
|
| Study Summary: |
|
During the study visit the research staff will ask about the medical history, perform a
brief physical exam, and draw approximately 4 teaspoons of blood of each family member.
|
| Criteria: |
|
Inclusion Criteria:
- Of Caucasian or African descent
- Families must have 2 natural/biological parents and 2 natural/biological offspring
- 6 years old or older
Exclusion Criteria:
- Races other than African American or Caucasian
- Families without 2 natural/biological parents and 2 natural/biological offspring
- younger that 6 years old
|
| NCT ID: |
|
NCT00853775 |
| Primary Contact: |
|
Principal Investigator
Lars Berglund, M.D., Ph.D.
University of California, Davis
Tina Tran
Phone: 916-703-9127
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Mather, California 95655
United States
There is no listed contact information for this specific location.
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 21, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|